- Home
- VCYT vs CBZ Comparison
VCYT vs CBZ Comparison
Compare VCYT & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCYT | CBZ |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCYT | CBZ |
|---|---|---|
| Price | $41.73 | $46.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $46.00 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 670.0K | 483.1K |
| Earning Date | 02-23-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.38 | ★ 1.66 |
| Revenue | $495,141,000.00 | ★ $2,675,607,000.00 |
| Revenue This Year | $16.46 | $55.61 |
| Revenue Next Year | $11.37 | $6.17 |
| P/E Ratio | $109.27 | ★ $30.64 |
| Revenue Growth | 16.41 | ★ 59.19 |
| 52 Week Low | $22.61 | $47.89 |
| 52 Week High | $50.71 | $90.13 |
Technical Indicators
Market Signals| Indicator | VCYT | CBZ |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 29.58 |
| Support Level | $40.29 | $53.25 |
| Resistance Level | $44.59 | $54.45 |
| Average True Range (ATR) | 1.69 | 1.89 |
| MACD | -0.27 | -0.57 |
| Stochastic Oscillator | 20.42 | 0.80 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.